Home
About
FAQ
History (6)
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Gray, Shaketha
Measurement of functional outcomes in the Major Extremity Trauma Research Consortium (METRC).
Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
The ketogenic diet for the treatment of pediatric status epilepticus.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (45)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
L. A. Koman MD
Wake Forest School of Medicine
Why?
Kathleen M. Kolaski MD
Wake Forest School of Medicine
Why?
Patrick M. McNutt PhD
Wake Forest School of Medicine
Why?
James F. Mooney
Wake Forest School of Medicine
Why?
Peter M. Waters MD
Why?
Chad A. Grotegut MD, MBA, MPH
Wake Forest School of Medicine
Why?
Lyndsay L. Madden DO
Wake Forest School of Medicine
Why?
Michael S. Cartwright MD
Wake Forest School of Medicine
Why?
Aarti Sarwal MD
Wake Forest School of Medicine
Why?
Araya Puwanant MD
Wake Forest School of Medicine
Why?
Kristen F. Nicholson PhD
Wake Forest School of Medicine
Why?
Anne E. Argenta MD
Wake Forest School of Medicine
Why?
Miranda E. Orr PhD
Wake Forest School of Medicine
Why?
James B. Caress MD
Wake Forest School of Medicine
Why?
J. M. Cline DVM, PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 3
Next
Prev
Search Criteria
Paralysis
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions